menu search

Why bionano genomics, pacific biosciences of california, and sangamo therapeutics stocks crumbled this week

These cutting-edge biotech companies quickly fell out of favor with investors this week....

February 10, 2023, 11:01 am

Betting on biotech

Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite ...

February 10, 2023, 10:02 am

Why shares of aura biosciences jumped this week

The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy....

February 10, 2023, 6:03 am

Molecular partners to present at svb leerink global healthcare conference

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...

February 10, 2023, 6:00 am

Molecular partners to present at svb leerink global healthcare conference

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage ...

February 10, 2023, 1:00 am

Prometheus biosciences to present at the svb securities global biopharma conference

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precisio...

February 9, 2023, 4:00 pm

Pharmaceutical companies losing patent protection as competition grows

The Wall Street Journal's Jared Hopkins joins 'Power Lunch' to discuss biotech patent protection durati...

February 9, 2023, 3:34 pm

Why compugen stock got slammed today

Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment....

February 8, 2023, 5:25 pm

2 top biotech stocks defying the bear market

These stocks soared in the double digits last year....

February 8, 2023, 2:00 pm

Design therapeutics to participate in the svb securities virtual global biopharma conference

CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treat...

February 8, 2023, 11:30 am

Sana biotechnology: time and cash burn are the enemies

It's a challenging time for biotechs needing cash. Sana Biotechnology is such a company from the stable of Boston-based Flagship Pioneering....

February 8, 2023, 11:21 am

Why is lixte biotech (lixt) stock down 29% today?

Lixte biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it's not due to any negative news from...

February 8, 2023, 8:54 am

1 beaten-down stock that has a lot to prove in 2023

This biotech looks like a high-risk, high-reward play....

February 8, 2023, 8:05 am

Cellectis announces closing of global offering and exercise of underwriters’ option to purchase additional shares

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinic...

February 8, 2023, 12:01 am

Tenaya therapeutics to participate in upcoming investor conferences

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with ...

February 7, 2023, 10:17 pm

Larimar therapeutics appoints dr. gopi shankar as chief development officer

Biologics expert and long-time veteran of Johnson & Johnson will be responsible for the strategic development of Larimar’s clinical and R&D programs...

February 7, 2023, 9:05 pm

Tenaya therapeutics to participate in upcoming investor conferences

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a...

February 7, 2023, 5:17 pm

Adicet bio: searching for upside in cell therapeutics

Biotechs developing CAR-T cell therapies have seen their valuations plummet in 2022 - making them an intriguing speculative buy opportunity in 2023. T...

February 7, 2023, 2:24 pm

The 7 best biotech stocks to buy for february 2023

While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech ...

February 7, 2023, 1:51 pm

Indaptus therapeutics activates morristown medical center as trial site in indp-d101, its ongoing phase 1 open label clinical trial of decoy20 in patients with advanced solid tumors

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company ...

February 7, 2023, 1:05 pm


Search within

Pages Search Results: